Copyright
©The Author(s) 2017.
World J Hepatol. Mar 8, 2017; 9(7): 385-390
Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.385
Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.385
Table 1 Characteristics of cases and controls
| Characteristic | Case (n = 94) | Control (n = 150) | P value | |
| Age, yr (mean ± SD) | 61.9 ± 9.4 | 58.0 ± 9.9 | 0.002 | |
| Gender | Female | 33% | 55% | < 0.001 |
| Male | 67% | 45% | ||
| Race | White | 85% | 80.0% | 0.605 |
| Black | 1% | 17% | ||
| Other | 14% | 3% | ||
| Ethnicity | Not Hispanic | 82% | 90% | 0.149 |
| Hispanic | 18% | 10% | ||
| Diabetes mellitus | Yes | 74% | 67% | 0.237 |
| No | 26% | 33% | ||
| Hypertension | Yes | 61% | 60% | 0.888 |
| No | 39% | 40% | ||
| Dyslipidemia | Yes | 50% | 47% | 0.609 |
| No | 50% | 53% | ||
| Cardiovascular disease | Yes | 28% | 19% | 0.093 |
| No | 72% | 81% | ||
| Metformin use | Yes | 40% | 37% | 0.660 |
| No | 60% | 63% | ||
| Statin use | Yes | 25% | 21% | 0.401 |
| No | 75% | 79% | ||
| Vitamin E use | Yes | 11% | 9% | 0.620 |
| No | 89% | 91% | ||
| Ascites | Yes | 51% | 47% | 0.628 |
| No | 49% | 53% | ||
| Gastroesophageal varices | Yes | 66% | 53% | 0.072 |
| No | 34% | 47% | ||
| Hepatic encephalopathy | Yes | 40% | 40% | 0.995 |
| No | 60% | 60% | ||
| Complications of cirrhosis | Yes | 83% | 71% | 0.032 |
| No | 17% | 29% | ||
| BMI (kg/m2) | 32.8 ± 5.8 | 33.9 ± 7.3 | 0.222 | |
| ALT (IU/L) (mean ± SD) | 43.3 ± 25.4 | 42.18 ± 37.3 | 0.819 | |
| MELD score (mean ± SD) | 11.6 ± 4.4 | 12.39 ± 4.8 | 0.382 |
- Citation: Corey KE, Gawrieh S, deLemos AS, Zheng H, Scanga AE, Haglund JW, Sanchez J, Danford CJ, Comerford M, Bossi K, Munir S, Chalasani N, Wattacheril J. Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World J Hepatol 2017; 9(7): 385-390
- URL: https://www.wjgnet.com/1948-5182/full/v9/i7/385.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i7.385